Business and People March 2014
Industry news focusing on the people and organizations who work in the clinical trials profession.
People
TrialNetworks (Needham, MA) announced the addition of Jose G. Guerra, MD, as Advisory Board Chairman. Guerra has been in the global biopharmaceutical industry for 30+ years, including 24 years at Merck.
ICON plc, (Dublin, Ireland) announced the appointment of Dariush Elahi, PhD, as Director of Metabolic Research. Based in ICON’s Clinical Pharmacology Unit in San Antonio, US, Elahi will lead ICON’s early phase glucose clamping programs globally.
INC Research (Camberley, UK) announced the appointment of two senior executives to its team. Asli Turkes, PhD, has joined as Vice President, Clinical Development, Oncology. Susan Timoney, PhD, has joined as Executive Director, Clinical Development, Oncology. INC also announced the addition of Beatrice Setnik, PhD, as Vice President, Clinical Pharmacology; and Jane Winter as Senior Vice President of its Global Consulting Unit.
Covance (Princeton, NJ) announced that Barry J. Goldstein, MD, PhD, has joined its Clinical Development Services business as Vice President and Global Therapeutic Area Head of the expanded Cardiovascular, Metabolic, and Scientific Affaris leadership team.
Vetter Development Services USA, Inc. (Chicago, IL) announced that President Claudia Roth, PhD, was elected to the board of the Illinois Biotechnology Industry Organization.
Synergy Research Group, (St. Petersburg, Russia) a Russia-based CRO, announced that John Barker has joined the company as COO. Barker’s role will be focused on expanding Synergy’s business into clients in the USA. Barker has previously served as VP of Project Management at Quintiles.
Waife & Associates, Inc. (Needham, MA) announced the addition of Senior Associate, Siegbert Kloos, to its staff.
The European Federation of Pharmaceutical Industries and Associations (EFPIA) (Brussels, Belgium) announced Liam English as its new Communications Director.
Exco InTouch (Sawbridgeworth, UK) announced the appointment of Laurence Burke as Vice President of Operations. His responsibilities include ensuring that processes are as streamlined and efficient as possible for customers, while also ensuring full continuity of robust delivery programs as Exco InTouch continues to grow the volume of its business.
Novella Clinical, (Stevenage, England) a Quintiles company, announced the addition of Chris Smyth, PhD, MBA, as their new Managing Director of European and Asian Operations.
CluePoints (Cambridge, MA) announced three new appointments to its global team. John Colby and Elizabeth Polvent join the company’s US Business Development Team. Jean Stéphenne, President of the Board of Directors of GlaxoSmithKline Biologicals, was welcomed as a member of its board.
Awards
ERT (Philadelphia, PA) announced that Philadelphia SmartCEO has recognized the company in its Future 50 Awards program. The program recognizes the region’s fastest-growing mid-sized and large Blue Chip companies that have experienced outsized growth based on a combined three-year average of revenue and employee growth.
Pharmaceutical Product Development, LLD (PPD) (Wilmington, NC) announced the company was ranked among the top US businesses for employee learning and development by Training magazine. The recognition marks the third consecutive ranking for PPD on the annual Training Top 125 list.
DAC Patient Recruitment Services (Dallas, TX) announced that it took home the gold in the 2014 AVA Digital Awards competition of writing, design, and execution of its DACTracks digital marketing campaign.
Forte Research Systems, Inc. (Madison, WI) announced that the Research Resonance Network received the Clinical Informatics News Best Practices Award in the category of Clinical Data Intelligence. The Research Resonance Network—which was developed through collaboration with research organizations and offers free tools for continuous improvement—was recognized for its standards-based approach to improving clinical research operations.
CTI Clinical Trial and Consulting Services (CTI) (Cincinnati, OH) was named Blue Ash Corporation of the Year by the Cincinnati USA Regional Chamber. The award recognizes outstanding companies in one of Cincinnati USA’s most vibrant business communities.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.
